Identification of cathepsin K as a novel marker of adiposity in white adipose tissue

Journal of Cellular Physiology

Volumn 195, Issue 2, 2003, Pages 309-321

  Chiellini, Chiara ^a   Costa, Mario ^b   Novelli, Silvia E ^c   Amri, Ez Zoubir ^d   Benzi, Luca ^a   Bertacca, Anna ^a   Cohen, Paul ^c   Del Prato, Stefano ^a   Friedman, Jeffrey M ^c   Maffei, Margherita ^a,e  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c ROCKEFELLER UNIVERSITY   (United States)

^d CENTRE DE BIOCHIMIE   (France)

^e CISANELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; CYSTEINE PROTEINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; LYSOSOME; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; OSTEOCLAST; PRIORITY JOURNAL; PROADIPOCYTE; RNA FINGERPRINTING; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BODY MASS INDEX; CATHEPSINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; OBESITY; RNA, MESSENGER; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0344643430     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10253     Document Type: Article

References (63)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1999. Current protocols in molecular biology. New York, NY: Wiley and Sons.
2. Baulande S, Lasnier F, Lucas M, Pairault J. 2001. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem 276:33336-33344.
3. Berk PD, Zhou S, Kiang C, Stump DD, Fan X, Bradbury MW. 1999. Selective up-regulation of fatty acid uptake by adipocytes characterizes both genetic and diet-induced obesity in rodents. J Biol Chem 274:28626-28631.
4. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA. 1996. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 21:12517-12524.
5. Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M. 2001. Adipocyte produces matrix metalloproteinases 2 and 9: Involvement in adipose differentiation. Diabetes 50:2080-2086.
6. Brömme D, Okamoto K. 1995. The baculovirus cysteine protease has a cathepsin B-like S2-subsite specificity. Biol Chem Hoppe Seyler 376:379-384.
7. Brömme D, Okamoto K, Wang BB, Biroc S. 1996. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem 271:2126-2132.
8. Bühling F, Reisenauer A, Gerber A, Krüger S, Weber E, Brömme D, Roessner A, Ansorge S, Welte T, Rocken Ch. 2001. Cathepsin K - a marker of macrophage differentiation? J Pathol 195:375-382.
9. Chapman HA, Riese RJ, Shi GP. 1997. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88.
10. Chiellini C, Bertacca A, Novelli SE, Görgün CZ, Ciccarone AM, Giordano A, Xu H, Soukas A, Costa M, Gandini D, Dimitri R, Bottone P, Cecchetti P, Pardini E, Perego L, Navalesi R, Folli F, Benzi L, Cinti S, Friedman JM, Hotamisligil GS, Maffei M. 2002. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFalpha. J Cell Physiol 190:251-258.
11. Cinti S. 2001. The adipose organ: Endocrine aspects and insights from transgenic models. Eat Weight Disord 6:4-8.
12. Civelek VN, Hamilton JA, Tornheim K, Kelly KL, Corkey BE. 1996. Intracellular pH in adipocytes: Effects of free fatty acid diffusion across the plasma membrane, lipolytic agonists, and insulin. Proc Natl Acad Sci USA 93:10139-10144.
13. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B. 1998. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401.
14. Consalez GG, Cabibbo A, Corradi A, Alli C, Sardella M, Sitia R, Fesce R. 1999. A computer-driven approach to PCR-based differential screening, alternative to differential display. Bioinformatics 15:93-105.
15. Corisdeo S, Gyda M, Zaidi M, Moonga BS, Troen BR. 2001. New insights into the regulation of cathepsin K gene expression by osteoprotegerin ligand. Biochem Biophys Res Commun 285:335-339.
16. Diment S, Martin KJ, Stahl PD. 1989. Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. J Biol Chem 264:13403-13406.
17. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Reiman D, Barthlow R, Hastings G, Gowen M. 1996. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-12516.
18. Frederich RC, Jr., Kahn BB, Peach MJ, Flier JS. 1992. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 19:339-344.
19. Gaumann A, Hansen T, Kohler HH, Kommoss F, Mann W, Maurer J, Kirkpatrick CJ, Kriegsmann J. 2001. The expression of cathepsins in osteoclast-like giant cells of an anaplastic thyroid carcinoma with tracheal perforation. Pathol Res Pract 197:257-262.
20. Gelb BD, Shi GP, Chapman HA, Desnick RJ. 1996. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
21. Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, Bertoncello I, Drake F, Zavarselk S, Tellis I, Hertzog P, Debouck C, Kola I. 1999. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654-1663.
22. Green H, Kehinde O. 1976. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell 7:105-113.
23. Gregoire FM, Smas CM, Sul HS. 1998. Understanding adipocyte differentiation. Physiol Rev 78:783-809.
24. Hansen T, Petrow PK, Gaumann A, Keyszer GM, Otto M, Kirkpatrick CJ, Kriegsmann J. 2001. Expression of cysteine proteinases cathepsins B and K and of cysteine proteinase inhibitor cystatin C in giant cell tumor of tendon sheath. Mod Pathol 14:318-324.
25. Herberg L, Coleman DL. 1977. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 26:59-99.
26. Hotamisligil GS, Spiegelman BM. 1994. Tumor necrosis factor alpha: A key component of the obesity-diabetes link. Diabetes 43:1271-1278.
27. Hou WS, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Bromme D. 2002. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium. Arthritis Rheum 46:663-674.
28. Huszar D, Lynch CA, Fairchild-Huntress W, Dunemore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141.
29. Inaoka T, Bilbe G, Ishibashi O, Tezuka K, Kumegawa M, Kokubo T. 1995. Molecular cloning of human cDNA for cathepsin K: Novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206:89-96.
30. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. 1995. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119.
31. Kersten S, Mandard S, Tan NS, Escher P, Metzger D, Chambon P, Gonzalez FJ, Desvergne B, Wahli W. 2000. Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275:28488-28493.
32. Knittle JL, Timmers K, Ginsberg-Fellner F. 1979. The growth of adipose tissue in children and adolescents. Cross-sectional and logitudinal study of adipose cell number and size. J Clin Invest 63:239-246.
33. Kopelman PG. 2000. Obesity as a medical problem. Nature 404:635-643.
34. Krude H, Grüters A. 2000. Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome. Trends Endocrinol Metab 11:15-22.
35. Lee GH, Proenca R, Montez JM, Carrol KM, Darvishzadeh JG, Lee JI, Friedman JM. 1996. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635.
36. Levine JA, Jensen MD, Eberhardt NL, O'Brien T. 1998. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest 101:1557-1564.
37. Levy C, Nechushtan H, Razin E. 2002. A new role for the STAT3 inhibitor, PIAS3: A repressor of microphthalmia transcription factor. J Biol Chem 277:1962-1966.
38. Maffei M, Fei H, Lee GH, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G, Friedman JM. 1995a. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA 92:6957-6960.
39. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. 1995b. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161.
40. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. 2002. Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47.
41. Moldes M, Lasnier F, Gauthereau X, Klein C, Pairault J, Feve B, Chambaut-Guerin AM. 2001. Tumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is highly induced by tumor necrosis factor-alpha and adipose conversion. J Biol Chem 276:33938-33946.
42. Montague CT, Farooqi S, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sawter CP, Digby JE, Mohammed SN, Hurst JA, Chetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. 1997. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908.
43. Motyckova G, Weilbaecher KN, Horstmann M, Reiman DJ, Fisher DZ, Fisher DE. 2001. Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci USA 98:5798-5803.
44. Naggert JK, Fricker LD, Varlamov O, Nishina PM, Rouille Y, Steiner DF, Carroll RJ, Paigen BJ, Leiter EH. 1995. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10:135-142.
45. Neel JV. 1962. Diabetes mellitus: A 'thrifty' genotype rendered detrimental by 'progress'? Am J Hum Genet 14:353-362.
46. Ranganathan S, Maffei M, Kern PA. 1998. Adipose tissue ob mRNA expression in humans: Discordance with plasma leptin and relationship with adipose TNFalpha expression. J Lipid Res 39:724-730.
47. Rodbell M. 1964. The metabolism of isolated fat cells. I. Effects of hormones of glucose metabolsim and lipolysis. J Biol Chem 239:375-380.
48. Roncari DAK, Lau DCW, Kindler S. 1981. Exaggerated replication in culture of adipocyte precursors from massively obese persons. Metabolism 30:425-427.
49. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K. 1998. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci USA 95:13453-13458.
50. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual. 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
51. Sasaki T, Gohring W, Mann K, Maurer P, Hohenester E, Knauper V, Murphy G, Timpl R. 1997. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272:9237-9243.
52. Soukas A, Cohen P, Socci ND, Friedman JM. 2000. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 14:963-980.
53. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. 2001. The hormone resistin links obesity to diabetes. Nature 409:307-312.
54. Söderstrom M, Ekfors T, Böhling T, Aho A, Aro HT, Vuorio E. 2001. Cysteine proteinases in chondrosarcomas. Matrix Biol 19:717-725.
55. Takahashi M, Nagaretani H, Funahashi T, Nishizawa H, Maeda N, Kishida K, Kuriyama H, Shimomura I, Maeda K, Hotta K, Ouchi N, Kihara S, Nakamura T, Yamashita S, Matsuzawa Y. 2001. The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. Obes Res 9:388-393.
56. Tartare-Deckert S, Chavey C, Monthouel MN, Gautier N, Van Obberghen E. 2001. The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. J Biol Chem 276:22231-22237.
57. Tepel C, Brömme D, Herzog V, Brix K. 2000. Cathepsin K in thyroid epithelial cells: Sequence, localization, and possible function in extracellular proteolysis of thyroglobulin. J Cell Sci 113:4487-4498.
58. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. 2000. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106:253-262.
59. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P. 2000. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 8:337-341.
60. Wang ZW, Zhou YT, Kakuma T, Lee Y, Higa M, Kalra SP, Dube MG, Kalra PS, Unger RH. 1999. Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia. Proc Natl Acad Sci USA 96:10373-10378.
61. Weigle DS, Kuijper JL. 1996. Obesity genes and the regulation of body fat content. BioEssays 18:867-874.
62. Weilbaecher KN, Motyckova G, Huber WE, Takemoto CM, Hemesath TJ, Xu Y, Hershey CL, Dowland NR, Wells AG, Fisher DE. 2001. Linkage ofM-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell 8:749-758.
63. Welsh J, Chada K, Dalal S, Cheng R, Ralph D, McClelland M. 1992. Arbitrarily primed PCR fingerprinting of RNA. Nucleic Acids Res 20:4965-4970.